• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将丁丙诺啡视为疼痛管理一线镇痛药的十二个理由。

Twelve reasons for considering buprenorphine as a frontline analgesic in the management of pain.

作者信息

Davis Mellar P

机构信息

Cleveland Clinic Lerner School of Medicine at Case Western University, OH 44195, USA.

出版信息

J Support Oncol. 2012 Nov-Dec;10(6):209-19. doi: 10.1016/j.suponc.2012.05.002. Epub 2012 Jul 17.

DOI:10.1016/j.suponc.2012.05.002
PMID:22809652
Abstract

Buprenorphine is an opioid that has a complex and unique pharmacology which provides some advantages over other potent mu agonists. We review 12 reasons for considering buprenorphine as a frontline analgesic for moderate to severe pain: (1) Buprenorphine is effective in cancer pain; (2) buprenorphine is effective in treating neuropathic pain; (3) buprenorphine treats a broader array of pain phenotypes than do certain potent mu agonists, is associated with less analgesic tolerance, and can be combined with other mu agonists; (4) buprenorphine produces less constipation than do certain other potent mu agonists, and does not adversely affect the sphincter of Oddi; (5) buprenorphine has a ceiling effect on respiratory depression but not analgesia; (6) buprenorphine causes less cognitive impairment than do certain other opioids; (7) buprenorphine is not immunosuppressive like morphine and fentanyl; (8) buprenorphine does not adversely affect the hypothalamic-pituitary-adrenal axis or cause hypogonadism; (9) buprenorphine does not significantly prolong the QTc interval, and is associated with less sudden death than is methadone; (10) buprenorphine is a safe and effective analgesic for the elderly; (11) buprenorphine is one of the safest opioids to use in patients in renal failure and those on dialysis; and (12) withdrawal symptoms are milder and drug dependence is less with buprenorphine. In light of evidence for efficacy, safety, versatility, and cost, buprenorphine should be considered as a first-line analgesic.

摘要

丁丙诺啡是一种阿片类药物,其药理学特性复杂且独特,相较于其他强效μ阿片受体激动剂具有一些优势。我们综述了将丁丙诺啡视为中度至重度疼痛一线镇痛药的12个理由:(1)丁丙诺啡对癌痛有效;(2)丁丙诺啡对治疗神经性疼痛有效;(3)与某些强效μ阿片受体激动剂相比,丁丙诺啡能治疗更广泛的疼痛表型,镇痛耐受性较低,且可与其他μ阿片受体激动剂联合使用;(4)与某些其他强效μ阿片受体激动剂相比,丁丙诺啡引起的便秘较少,且对Oddi括约肌无不良影响;(5)丁丙诺啡对呼吸抑制有封顶效应,但对镇痛无此效应;(6)与某些其他阿片类药物相比,丁丙诺啡引起的认知障碍较少;(7)丁丙诺啡不像吗啡和芬太尼那样具有免疫抑制作用;(8)丁丙诺啡不会对下丘脑-垂体-肾上腺轴产生不良影响,也不会导致性腺功能减退;(9)丁丙诺啡不会显著延长QTc间期,与美沙酮相比,猝死风险较低;(10)丁丙诺啡对老年人是一种安全有效的镇痛药;(11)丁丙诺啡是肾衰竭患者和透析患者使用的最安全的阿片类药物之一;(12)丁丙诺啡的戒断症状较轻,药物依赖性较小。鉴于丁丙诺啡在疗效、安全性、多功能性和成本方面的证据,应将其视为一线镇痛药。

相似文献

1
Twelve reasons for considering buprenorphine as a frontline analgesic in the management of pain.将丁丙诺啡视为疼痛管理一线镇痛药的十二个理由。
J Support Oncol. 2012 Nov-Dec;10(6):209-19. doi: 10.1016/j.suponc.2012.05.002. Epub 2012 Jul 17.
2
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).阿片类药物与老年人慢性重度疼痛的管理:一个国际专家小组的共识声明,重点关注世界卫生组织第三阶梯临床最常用的六种阿片类药物(丁丙诺啡、芬太尼、氢吗啡酮、美沙酮、吗啡、羟考酮)。
Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.
3
Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine.丁丙诺啡透皮贴剂的药理学、疗效及安全性临床进展
Eur J Pain. 2009 Mar;13(3):219-30. doi: 10.1016/j.ejpain.2008.04.011. Epub 2008 Jun 24.
4
Transdermal buprenorphine controls central neuropathic pain.透皮丁丙诺啡可控制中枢性神经性疼痛。
J Opioid Manag. 2012 Nov-Dec;8(6):414-5. doi: 10.5055/jom.2012.0141.
5
Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice.μ-阿片受体激动剂和拮抗剂与丁丙诺啡对小鼠镇痛作用的相互作用。
Eur J Pain. 2005 Oct;9(5):599-611. doi: 10.1016/j.ejpain.2005.02.002.
6
Opioid-induced respiratory effects: new data on buprenorphine.阿片类药物引起的呼吸效应:丁丙诺啡的新数据。
Palliat Med. 2006;20 Suppl 1:s3-8.
7
The role of transdermal buprenorphine in the treatment of cancer pain: an expert panel consensus.经皮丁丙诺啡在癌痛治疗中的作用:专家小组共识。
Curr Med Res Opin. 2009 Jun;25(6):1517-28. doi: 10.1185/03007990902920731.
8
Opioid and adjuvant analgesics: compared and contrasted.阿片类和辅助镇痛药:比较与对比
Am J Hosp Palliat Care. 2011 Aug;28(5):378-83. doi: 10.1177/1049909111410298. Epub 2011 May 26.
9
Transdermal buprenorphine in cancer pain and palliative care.透皮丁丙诺啡用于癌症疼痛及姑息治疗。
Palliat Med. 2006;20 Suppl 1:s25-30.
10
Safety and efficacy of transdermal buprenorphine and transdermal fentanyl in the treatment of neuropathic pain in AIDS patients.经皮丁丙诺啡和经皮芬太尼治疗 AIDS 患者神经病理性疼痛的安全性和有效性。
Minerva Anestesiol. 2013 Aug;79(8):871-83. Epub 2013 Apr 5.

引用本文的文献

1
Transdermal buprenorphine patch in the management of post-operative pain in orthopaedic patients: a systematic review looking at efficacy, safety, adverse effects and cost-benefit analysis.丁丙诺啡透皮贴剂用于骨科患者术后疼痛管理:一项关于疗效、安全性、不良反应及成本效益分析的系统评价
Eur J Orthop Surg Traumatol. 2025 May 30;35(1):221. doi: 10.1007/s00590-025-04334-0.
2
Strategy for effective analgesia with intravenous buprenorphine in patients with acute postoperative pain.急性术后疼痛患者静脉注射丁丙诺啡的有效镇痛策略。
BMC Anesthesiol. 2025 Apr 26;25(1):216. doi: 10.1186/s12871-025-03084-0.
3
Providers' Barriers to Buprenorphine Prescribing for Cancer-Related Pain.
医疗服务提供者在开具丁丙诺啡治疗癌症相关疼痛时面临的障碍。
J Pain Symptom Manage. 2025 May;69(5):e330-e336. doi: 10.1016/j.jpainsymman.2025.02.010. Epub 2025 Feb 16.
4
Is the Use of a Buprenorphine Transdermal Patch More Effective Than Oral Medications for Postoperative Analgesia After Arthroscopic Rotator Cuff Repair? A Randomized Clinical Trial.对于关节镜下肩袖修补术后的镇痛,丁丙诺啡透皮贴剂的使用是否比口服药物更有效?一项随机临床试验。
Clin Orthop Relat Res. 2025 May 1;483(5):857-865. doi: 10.1097/CORR.0000000000003303. Epub 2024 Nov 5.
5
Risk of infections among persons treated with opioids for chronic pain: a systematic review and meta-analysis protocol.慢性疼痛接受阿片类药物治疗人群的感染风险:系统评价和荟萃分析方案。
BMJ Open. 2024 Oct 15;14(10):e083791. doi: 10.1136/bmjopen-2023-083791.
6
Transdermal buprenorphine patch as an adjunct to multimodal analgesia after total joint arthroplasty: a retrospective cohort study.透皮丁丙诺啡贴剂作为全关节置换术后多模式镇痛的辅助治疗:一项回顾性队列研究。
Front Pharmacol. 2024 Sep 20;15:1412099. doi: 10.3389/fphar.2024.1412099. eCollection 2024.
7
Frontline Perspectives on Buprenorphine for the Management of Chronic Pain.丁丙诺啡用于慢性疼痛管理的一线观点
J Multidiscip Healthc. 2024 Mar 27;17:1375-1383. doi: 10.2147/JMDH.S449748. eCollection 2024.
8
Buprenorphine for Chronic Pain Management: a Narrative Review.丁丙诺啡用于慢性疼痛管理:叙述性综述。
Curr Pain Headache Rep. 2023 Dec;27(12):811-820. doi: 10.1007/s11916-023-01185-4. Epub 2023 Oct 28.
9
Opioid Prescription in Patients With Chronic Kidney Disease: A Systematic Review of Comparing Safety and Efficacy of Opioid Use in Chronic Kidney Disease Patients.慢性肾脏病患者的阿片类药物处方:关于比较慢性肾脏病患者使用阿片类药物安全性和有效性的系统评价
Cureus. 2023 Sep 18;15(9):e45485. doi: 10.7759/cureus.45485. eCollection 2023 Sep.
10
Climbing behavior by mice as an endpoint for preclinical assessment of drug effects in the absence and presence of pain.在有无疼痛的情况下,将小鼠的攀爬行为作为药物作用临床前评估的一个终点指标。
Front Pain Res (Lausanne). 2023 Apr 17;4:1150236. doi: 10.3389/fpain.2023.1150236. eCollection 2023.